Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Liminal BioSciences Inc. PFSCF


Primary Symbol: LMNL

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.


NDAQ:LMNL - Post by User

Post by inventorson Apr 30, 2021 11:44am
145 Views
Post# 33101349

Out preforming...

Out preforming...Wow, couldn't imagine lmnl still being alive, cleaned up, and saved from vulture hedge funds in stealing it all....leaving ZERO.

There is hope, strength, new beginings, and a great future....thanks to Thomvest.

Originally, coming in at 0.07- 0.14 cents through to phase 3 science.

Valant? stole the show 7 years ago, and took the market down $400 all the way down to roll over, then split co, now Bausch healthcare.

Then a few years ago Canopy and pot market stole the show.

Now, Covid 19 is stealing the show.

This past major cycle in healthcare, major distribution consolidation, and big pharma too.

Today, Biotech, grass roots biotech with orphan unmet autoimmunity will win.

And so will LMNL.
<< Previous
Bullboard Posts
Next >>